March 23 (Reuters) - Britain's FTSE 100 index is seen opening up 12
points at 7,337 on Thursday, according to financial bookmakers.
* GLAXOSMITHKLINE: Britain's GlaxoSmithKline and U.S.-based
Regeneron Pharmaceuticals are embarking on a joint project with UK
Biobank, the world's most detailed biomedical database, to hunt for new clues
linking genes and disease.
* SHELL: Royal Dutch Shell agreed to lease capacity at a large oil
terminal in Panama that has been used by U.S. re
Read more
No comments:
Post a Comment